InvestorsHub Logo
Followers 170
Posts 8965
Boards Moderated 0
Alias Born 01/24/2011

Re: None

Friday, 01/13/2017 3:39:53 PM

Friday, January 13, 2017 3:39:53 PM

Post# of 329081
Motion to Correct Manifest Errors of Fact Denied

As I wrote in response to comments about the 10th Circuit Court of Appeals ruling, ALJ Elliot is still on the BIEL case in Maryland, and today he issued a ruling denying BIEL's Motion to Correct Manifest Errors of Fact.

When the motion was first filed a few weeks ago, he gave the Division (SEC) until Jan 12 to file their response, and they did file one, but either they filed it early, or the decision was so easy that even if the Division filed it yesterday, he was still able to get the denial written and filed today.

Here's the text of the denial, and you can see how trivial BIEL's objections were (Note: BIEL, Whelan, et al are the Respondents):

On December 13, 2016, I issued an initial decision as to Respondents BioElectronics Corp., IBEX, LLC, St. John’s, LLC, Andrew J. Whelan, and Kelly A. Whelan, CPA. BioElectronics Corp., Initial Decision Release No. 1089, 2016 SEC LEXIS 4597. On December 23, 2016, Respondents filed a motion to correct manifest errors of fact in the initial decision, pursuant to 17 C.F.R. § 201.111(h). The Division of Enforcement timely filed an opposition.

A manifest error is “an error that is plain and indisputable, and that amounts to a complete disregard of... the credible evidence in the record.” Robert Cord Beatty, Admin. Proc. Rulings Release No. 618, 2005 SEC LEXIS 359, at *8 ( ALJ Feb. 10, 2005) ( quoting Black’s Law Dictionary 563 (7th ed. 1999)), finality notice, Securities Act of 1933 Release No. 8554, 2005 SEC LEXIS 622 (Mar. 16, 2005). For an error of fact to be manifest, it must be an error that could reasonably affect the outcome of the decision. See Raymond James Fin. Servs., Inc., Admin. Proc. Rulings Release No. 622, 2005 WL 3778678, at *1 (ALJ Oct. 14, 2005), finality notice, Exchange Act Release No. 52810, 2005 WL 3108488 (Nov. 21, 2005). A motion contesting the substantive merits of the initial decision may no t be brought under Rule 111(h). See Adoption of Amendments to the Rules of Practice and Related Provisions and Delegations of Authority of the Commission, 70 Fed. Reg. 72566, 72567 (Dec. 5, 2005).

The bulk of Respondents’ motion is devoted to purely legal issues, which may not be contested under Rule 111(h). And t hose portions of the motion asserting manifest errors of fact are meritless. For example, Respondent s dispute six factual assertions in the initial decision 1 pertaining broadly to the testimony of Brian Flood, one of Respondents’ expert witnesses. See Motion at 17 - 20. In support of their arguments, Respondents submitted a “Post - Hearing Declaration of Brian Flood, ” which may not be considered because it is not part of the hearing record, and which therefore cannot establish a manifest error of fact. I have in any event carefully reviewed the six factual assertions Respondents contend are erroneous, and find no error in them, manifest or otherwise.

Respondents dispute two other factual assertions in the initial decision. First, they dispute the alleged “finding that BioElectronics had 16,011 share holders of record in 2009.” Motion at 24. But the initial decision made no such finding; instead, it observed that “BIEL reported that as of December 31, 2009, it had 16,011 holders of record of its common stock,” and “there is evidence that as of December 31, 2009, BIEL... common stock was held of record by 16,011 persons.” BioElectronics Corp., 2016 SEC LEXIS 4597, at *22, *93 (Dec. 13, 2016) (citing DX 51 at 16). These observations were accurate, a point Respondents concede. See Motion at 22, 24.

Second, Respondents contend that Flood’s “detailed calculation of the aggregate proceeds [of IBEX’s securities sales] is slightly different” from the calculation in the initial decision. Motion at 15. But Flood’s post - initial decision calculation is inconsistent with the stipulated aggregate proceeds – $1,639,841 (stock sales) plus $2,656,425 (note sales) equals $4,296,266 – and may not be considered in any event because the calculation is not part of the hearing record. See Stipulation at Ex. B.

Respondents’ motion to correct manifest errors of fact is therefore DENIED.


The proceeding has ended as to Respondent Robert P. Bedwell, CPA. BioElectronics Corp., Securities Exchange Act of 1934 Release No. 79176, 2016 SEC LEXIS 4034 (Oct. 27, 2016). [Emphasis added by DRT]


https://www.sec.gov/alj/aljorders/2017/ap-4522.pdf


BEIL's next step will be to file an appeal with the Commission, though it's possible they might try to short circuit it on constitutional grounds.


"Soylent Green is people!!!"

Detective Robert Thorn: Telling uncomfortable truths since 2022

DRT is Charleton Heston's character in the 1973 movie, Soylent Green, set in the year 2022, and is not my real name